Comments on the theory, methods, and potential of the sepsis-detecting Cytovale System from Cytovale CEO and co-founder, Ajay Shah, Ph.D.
Australian researchers found that T cells engineered to express the dendritic cell growth factor Flt3L overcame an important obstacle to the treatment of solid tumors.
Portuguese researchers discovered that type 1 regulatory T cells increase the availability of TGF-beta to promote CD8+ TRM T cell generation.
Disulfiram, a drug approved by the FDA for treating alcohol addiction, has been found to antagonize inflammation and could treat key diseases .
Research by Dr. Arne Akbar and colleagues has shown that NK cell-like behavior of aging CD8+ T cells is linked to the expression of sestrins.
A physician, Dr. Giovanni Monteleone MD PhD, outlines the implications of COVID-19 for Ulcerative Colitis and Crohn’s Disease patients.
Limited Efficacy of Immunosuppressive Strategy in Transplant Patients Associated with Immunoproteosome
The limited efficacy of a proteosome inhibitor-based immunosuppressive strategy in highly HLA-sensitized transplant recipients has been associated with the immunoproteosome.
Novel engineered nanoparticles have the ability to selectively deliver immune checkpoint blockade (ICB) therapy to tumors, allowing for targeted immunotherapy that is more efficient and has reduced side effects.
Genetic Variants of Receptor Detecting Inflammation and Tissue Damage May Increase Susceptibility for Depression
Genetic variants of an innate immune receptor that detects inflammation and tissue damage have been associated with HADS depression severity scores and susceptibility for depression by a group of Hungarian researchers.